The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

David S. Goodsell

Department of Molecular Biolgy

Scripps Research Institute

La Jolla

CA 92037

USA

[email]@scripps.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Molecular Biolgy, Scripps Research Institute, La Jolla, CA 92037, USA. 2000 - 2010
  • The Scripps Research Institute, Department of Molecular Biology, La Jolla, California 92037, USA. 1999 - 2007

References

  1. Artophagy: the art of autophagy--the Cvt pathway. Goodsell, D.S., Klionsky, D.J. Autophagy (2010) [Pubmed]
  2. The molecular perspective: hepatitis B virus. Goodsell, D.S. Oncologist (2007) [Pubmed]
  3. Making the step from chemistry to biology and back. Goodsell, D.S. Nat. Chem. Biol. (2007) [Pubmed]
  4. Filling in the gaps: artistic license in education and outreach. Goodsell, D.S., Johnson, G.T. PLoS Biol. (2007) [Pubmed]
  5. The molecular perspective: tumor necrosis factor. Goodsell, D.S. Oncologist (2006) [Pubmed]
  6. The molecular perspective: c-Abl tyrosine kinase. Goodsell, D.S. Stem. Cells (2006) [Pubmed]
  7. The molecular perspective: cisplatin. Goodsell, D.S. Oncologist (2006) [Pubmed]
  8. The molecular perspective: Cisplatin. Goodsell, D.S. Stem. Cells (2006) [Pubmed]
  9. The molecular perspective: estrogen sulfotransferase. Goodsell, D.S. Oncologist (2006) [Pubmed]
  10. Recognition highlights: Toll-like receptors. Goodsell, D.S. J. Mol. Recognit. (2006) [Pubmed]
  11. The molecular perspective: tissue factor. Goodsell, D.S. Oncologist (2006) [Pubmed]
  12. The molecular perspective: alcohol. Goodsell, D.S. Oncologist (2006) [Pubmed]
  13. The molecular perspective: morphine. Goodsell, D.S. Stem. Cells (2005) [Pubmed]
  14. The molecular perspective: major histocompatibility complex. Goodsell, D.S. Oncologist (2005) [Pubmed]
  15. The molecular perspective: major histocompatibility complex. Goodsell, D.S. Stem. Cells (2005) [Pubmed]
  16. Visual methods from atoms to cells. Goodsell, D.S. Structure (2005) [Pubmed]
  17. The molecular perspective: L-asparaginase. Goodsell, D.S. Oncologist (2005) [Pubmed]
  18. The molecular perspective: l-asparaginase. Goodsell, D.S. Stem. Cells (2005) [Pubmed]
  19. The molecular perspective: double-stranded DNA breaks. Goodsell, D.S. Oncologist (2005) [Pubmed]
  20. Recognition in action: flipping pyrimidine dimers. Goodsell, D.S. J. Mol. Recognit. (2005) [Pubmed]
  21. The molecular perspective: double-stranded DNA breaks. Goodsell, D.S. Stem. Cells (2005) [Pubmed]
  22. The molecular perspective: RAD51 and BRCA2. Goodsell, D.S. Oncologist (2005) [Pubmed]
  23. Recognition in action: DNA mimicry. Goodsell, D.S. J. Mol. Recognit. (2005) [Pubmed]
  24. The molecular perspective: RAD51 and BRCA2. Goodsell, D.S. Stem. Cells (2005) [Pubmed]
  25. The molecular perspective: c-Abl tyrosine kinase. Goodsell, D.S. Oncologist (2005) [Pubmed]
  26. The molecular perspective: protein farnesyltransferase. Goodsell, D.S. Stem. Cells (2004) [Pubmed]
  27. The molecular perspective: DNA polymerase. Goodsell, D.S. Oncologist (2004) [Pubmed]
  28. The molecular perspective: DNA polymerase. Goodsell, D.S. Stem. Cells (2004) [Pubmed]
  29. The molecular perspective: cytochrome C and apoptosis. Goodsell, D.S. Oncologist (2004) [Pubmed]
  30. The molecular perspective: Cytochrome C and apoptosis. Goodsell, D.S. Stem. Cells (2004) [Pubmed]
  31. The molecular perspective: nicotine and nitrosamines. Goodsell, D.S. Oncologist (2004) [Pubmed]
  32. The molecular perspective: polycyclic aromatic hydrocarbons. Goodsell, D.S. Oncologist (2004) [Pubmed]
  33. The molecular perspective: nicotine and nitrosamines. Goodsell, D.S. Stem. Cells (2004) [Pubmed]
  34. The molecular perspective: polycyclic aromatic hydrocarbons. Goodsell, D.S. Stem. Cells (2004) [Pubmed]
  35. The molecular perspective: cyclins. Goodsell, D.S. Oncologist (2004) [Pubmed]
  36. The molecular perspective: cyclins. Goodsell, D.S. Stem. Cells (2004) [Pubmed]
  37. The molecular perspective: morphine. Goodsell, D.S. Oncologist (2004) [Pubmed]
  38. The molecular perspective: VEGF and angiogenesis. Goodsell, D.S. Stem. Cells (2003) [Pubmed]
  39. The molecular perspective: ubiquitin and the proteosome. Goodsell, D.S. Oncologist (2003) [Pubmed]
  40. The molecular perspective: ubiquitin and the proteosome. Goodsell, D.S. Stem. Cells (2003) [Pubmed]
  41. The molecular perspective: histone deacetylase. Goodsell, D.S. Stem. Cells (2003) [Pubmed]
  42. The molecular perspective: epidermal growth factor. Goodsell, D.S. Oncologist (2003) [Pubmed]
  43. The molecular perspective: epidermal growth factor. Goodsell, D.S. Stem. Cells (2003) [Pubmed]
  44. The molecular perspective: protein farnesyltransferase. Goodsell, D.S. Oncologist (2003) [Pubmed]
  45. Looking at molecules-an essay on art and science. Goodsell, D.S. Chembiochem (2003) [Pubmed]
  46. The molecular perspective: antibodies. Goodsell, D.S. Stem. Cells (2002) [Pubmed]
  47. The molecular perspective: restriction endonucleases. Goodsell, D.S. Oncologist (2002) [Pubmed]
  48. The molecular perspective: restriction endonucleases. Goodsell, D.S. Stem. Cells (2002) [Pubmed]
  49. The molecular perspective: tamoxifen and the estrogen receptor. Goodsell, D.S. Oncologist (2002) [Pubmed]
  50. The molecular perspective: tamoxifen and the estrogen receptor. Goodsell, D.S. Stem. Cells (2002) [Pubmed]
  51. The molecular perspective: Bcl-2 and apoptosis. Goodsell, D.S. Oncologist (2002) [Pubmed]
  52. The molecular perspective: Bcl-2 and apoptosis. Goodsell, D.S. Stem. Cells (2002) [Pubmed]
  53. The molecular perspective: DNA topoisomerases. Goodsell, D.S. Oncologist (2002) [Pubmed]
  54. The molecular perspective: DNA topoisomerases. Goodsell, D.S. Stem. Cells (2002) [Pubmed]
  55. The molecular perspective: cadherin. Goodsell, D.S. Oncologist (2002) [Pubmed]
  56. The molecular perspective: cadherin. Goodsell, D.S. Stem. Cells (2002) [Pubmed]
  57. The molecular perspective: VEGF and angiogenesis. Goodsell, D.S. Oncologist (2002) [Pubmed]
  58. The molecular perspective: targeted toxins. Goodsell, D.S. Oncologist (2001) [Pubmed]
  59. The molecular perspective: the ribosome. Goodsell, D.S. Stem. Cells (2001) [Pubmed]
  60. The molecular perspective: targeted toxins. Goodsell, D.S. Stem. Cells (2001) [Pubmed]
  61. Sequence recognition of DNA by lexitropsins. Goodsell, D.S. Curr. Med. Chem. (2001) [Pubmed]
  62. The molecular perspective: cytochrome p450. Goodsell, D.S. Oncologist (2001) [Pubmed]
  63. The molecular perspective: cytochrome P450. Goodsell, D.S. Stem. Cells (2001) [Pubmed]
  64. The molecular perspective: ultraviolet light and pyrimidine dimers. Goodsell, D.S. Oncologist (2001) [Pubmed]
  65. The molecular perspective: ultraviolet light and pyrimidine dimers. Goodsell, D.S. Stem. Cells (2001) [Pubmed]
  66. The molecular perspective: interferons. Goodsell, D.S. Oncologist (2001) [Pubmed]
  67. The molecular perspective: interferons. Goodsell, D.S. Stem. Cells (2001) [Pubmed]
  68. The molecular perspective: the Src oncogene. Goodsell, D.S. Stem. Cells (2001) [Pubmed]
  69. The molecular perspective: antibodies. Goodsell, D.S. Oncologist (2001) [Pubmed]
  70. The molecular perspective: matrix metalloproteinase 2. Goodsell, D.S. Stem. Cells (2000) [Pubmed]
  71. The molecular perspective: DNA. Goodsell, D.S. Oncologist (2000) [Pubmed]
  72. The molecular perspective: DNA. Goodsell, D.S. Stem. Cells (2000) [Pubmed]
  73. The molecular perspective: cyclooxygenase-2. Goodsell, D.S. Oncologist (2000) [Pubmed]
  74. The molecular perspective: cyclooxygenase-2. Goodsell, D.S. Stem. Cells (2000) [Pubmed]
  75. The molecular perspective: simian virus 40. Goodsell, D.S. Oncologist (2000) [Pubmed]
  76. The molecular perspective: simian virus 40. Goodsell, D.S. Stem. Cells (2000) [Pubmed]
  77. Structural symmetry and protein function. Goodsell, D.S., Olson, A.J. Annu. Rev. Biophys. Biomol. Struct (2000) [Pubmed]
  78. The molecular perspective: microtubules and the taxanes. Goodsell, D.S. Oncologist (2000) [Pubmed]
  79. The art of molecular graphics. Goodsell, D.S., Gaber, B.P. J. Mol. Graph. Model. (2000) [Pubmed]
  80. The molecular perspective: microtubules and the taxanes. Goodsell, D.S. Stem. Cells (2000) [Pubmed]
  81. The molecular perspective: caspases. Goodsell, D.S. Oncologist (2000) [Pubmed]
  82. The molecular perspective: caspases. Goodsell, D.S. Stem. Cells (2000) [Pubmed]
  83. The molecular perspective: the ribosome. Goodsell, D.S. Oncologist (2000) [Pubmed]
  84. The molecular perspective: p53 tumor suppressor. Goodsell, D.S. Oncologist (1999) [Pubmed]
  85. The molecular perspective: the ras oncogene. Goodsell, D.S. Oncologist (1999) [Pubmed]
  86. The molecular perspective: methotrexate. Goodsell, D.S. Oncologist (1999) [Pubmed]
  87. The molecular perspective: the multidrug transporter. Goodsell, D.S. Oncologist (1999) [Pubmed]
  88. The molecular perspective: matrix metalloproteinase 2. Goodsell, D.S. Oncologist (1999) [Pubmed]
  89. The art of molecular graphics. The 1998 Molecular Graphics Art Show. Goodsell, D.S. J. Mol. Graph. Model. (1999) [Pubmed]
 
WikiGenes - Universities